Trial Information

Summary: Predicting Response to Treatment with Antidepressants

This study uses brain imaging technology (PET scans) to learn about changes in brain chemistry related to depression. The goal is to use this technology to predict which treatments will be the most effective for individuals with depression. As a part of study participation, patients receive no-cost outpatient treatment for five months, or inpatient treatment, depending on their clinical needs. Treatment is with antidepressant medications. All subjects will receive medication treatment; there are no placebos used in this study. You will be paid up to $415 for your time if you are eligible and choose to participate. Further information is also available at our website:

http://www.depression-studies.org

Benefits to participant:

• Free, thorough clinical evaluation by doctoral-level psychologist and psychiatrist
• No-cost Outpatient or Inpatient treatment

Patient Inclusion Criteria

• Ages 18 to 65
• Meets criteria for Major Depressive Disorder
• Currently depressed

Patient Exclusion Criteria

• Current alcohol/substance abuse or dependence.
• Pregnancy (Currently pregnant or lactating; planning to conceive during the course of study participation).
• Unstable medical conditions

If you would like to learn more about participating in this study, please send an e-mail message using the form below.